THE BRITISH INHERITED METABOLIC DISEASE GROUP
To relieve, for the benefit of the public, persons suffering from inherited metabolic disease by advancing the education of professionals involved in their diagnosis, care and treatment; and To promote, for the benefit of the public, research into the treatment of inherited metabolic disease.
Objects
THE OBJECTS OF THE CIO ARE:3.1 TO RELIEVE, FOR THE BENEFIT OF THE PUBLIC, PERSONS SUFFERING FROM INHERITED METABOLIC DISEASE BY ADVANCING THE EDUCATION OF PROFESSIONALS INVOLVED IN THEIR DIAGNOSIS, CARE AND TREATMENT; AND3.2 TO PROMOTE, FOR THE BENEFIT OF THE PUBLIC, RESEARCH INTO THE TREATMENT OF INHERITED METABOLIC DISEASE.
Financial health, per its FY2025 accounts
The accounts state that total income decreased to £144,107 from £169,129 in the prior year, while total expenditure fell more significantly to £101,887 from £176,921. Consequently, unrestricted reserves increased to £101,863, which the Trustees confirm are held to ensure the charity's objectives can be satisfied. The trustees report adequate resources for the foreseeable future, confirming the going concern basis.
What the accounts disclose
“symposium income of £134,819” — page 5
“The policy of the Charity is to ensure that positive reserves exist in an unrestricted fund to ensure that the objectives of the Charity can be satisfied.” — page 5
Policies the charity declares
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Safeguarding policy and procedures
- Serious incident reporting policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
Register events
- Received assets from another charity (11/01/2020)
Trustees
- Dr James Edward Davisonchair
- Aye Myat Moe
- Bernadette Catherine O'Reilly
- Charlotte Helen Dawson
- Dr Amanda Lam
- Dr Bernd Schwahn
- Dr Donna Maria Fullerton
- Dr Eamon McCarron
- Dr Germaine Pierre
- Dr Katie Redwood
- Dr Laura Hancox
- Dr Marianne Barr
- Dr Nathan Cantley
- Dr Nishan Guha
- Dr Saikat Santra
- Dr Sergei Korenev
- Dr Sherry Fang
- Elizabeth Caller
- Elizabeth Morris
- Faiza Adrees
- Hoi Yee Wu
- Jennie Freestone
- Louise Victoria Robertson
- Melanie Jayne Mcsweeney
- Rachel Helen Skeath MSc
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £144k | £102k |
| 31/12/2024 | £13k | £21k |
| 31/12/2023 | £13k | £9k |
| 31/12/2022 | £14k | £21k |
| 31/12/2021 | £12k | £6k |
Common questions
Is THE BRITISH INHERITED METABOLIC DISEASE GROUP financially healthy?
Per its FY2025 accounts: The accounts state that total income decreased to £144,107 from £169,129 in the prior year, while total expenditure fell more significantly to £101,887 from £176,921. Consequently, unrestricted reserves increased to £101,863, which the Trustees confirm are held to ensure the charity's objectives can be satisfied. The trustees report adequate resources for the foreseeable future, confirming the going concern basis. Its FY2025 accounts were independently examined.